Oric Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORIC and other ETFs, options, and stocks.

About ORIC

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. 

CEO
Jacob M. Chacko
CEOJacob M. Chacko
Employees
115
Employees115
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2014
Founded2014
Employees
115
Employees115

ORIC Key Statistics

Market cap
937.47M
Market cap937.47M
Price-Earnings ratio
-5.92
Price-Earnings ratio-5.92
Dividend yield
—
Dividend yield—
Average volume
566.86K
Average volume566.86K
High today
$11.41
High today$11.41
Low today
$10.88
Low today$10.88
Open price
$11.26
Open price$11.26
Volume
474.35K
Volume474.35K
52 Week high
$14.67
52 Week high$14.67
52 Week low
$3.90
52 Week low$3.90

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ORIC. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
NIO
Lucid Group
Tilray Brands
Pfizer
Alibaba
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.